ADC Therapeutics ADCT
NYSE ADCT
$1.58 +0.08 (+5.00%)
As of: Oct 22, 2026 · 12:45 PM EDT

ADC Therapeutics (ADCT) Liabilities and Shareholders Equity (2019 - 2026)

Updated

ADC Therapeutics' Liabilities and Shareholders Equity was $279.38 million in Q2 2026, down 13.1% from $321.56 million a year earlier and down 4.2% from the prior quarter.

Analysis

ADC Therapeutics (ADCT) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at ADC Therapeutics came in at $323.15 million, up 0.4% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -8.9% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $321.98 million in FY2024 (-9.2%), $354.78 million in FY2023 (-27.7%), $490.86 million in FY2022 (-20.6%) and $617.97 million in FY2021 (+20.3%).
  • The Q2 2026 figure marks the lowest quarterly Liabilities and Shareholders Equity since Q1 2025.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in two of the last eight quarters, with an average decline of 10.3%.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q1 2022 (growth of 26.0%); the worst was Q1 2024 (a decline of 34.1%).
  • Per Business Quant data, ADCT's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $291.5 million (Q1 2026), $323.15 million (Q4 2025) and $289.76 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,169.59 Bn 1,138.18 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 643.18 Bn 561.71 Bn 17.26 Bn 201.06 Bn
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn 135.12 Bn
4 Merck 361.55 Bn 315.92 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 302.33 Bn 266.32 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 267.31 Bn 241.00 Bn 12.86 Bn 115.83 Bn
7 Amgen 241.52 Bn 196.92 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 193.17 Bn 167.37 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn 201.13 Bn
10 ADC Therapeutics 244.15 Mn -702.04 Mn 16.90 Mn 279.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 279.38 Mn
Mar 31, 2026 291.50 Mn
Dec 31, 2025 323.15 Mn
Sep 30, 2025 289.76 Mn
Jun 30, 2025 321.56 Mn
Mar 31, 2025 272.54 Mn
Dec 31, 2024 321.98 Mn
Sep 30, 2024 349.08 Mn
Jun 30, 2024 371.78 Mn
Mar 31, 2024 307.97 Mn
Dec 31, 2023 354.78 Mn
Sep 30, 2023 466.90 Mn
Jun 30, 2023 507.30 Mn
Mar 31, 2023 467.67 Mn
Dec 31, 2022 490.86 Mn
Sep 30, 2022 531.76 Mn
Jun 30, 2022 520.46 Mn
Mar 31, 2022 581.89 Mn
Dec 31, 2021 617.97 Mn
Sep 30, 2021 637.98 Mn
API Access

ADC Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ADCT&period=max&api_key=YOUR_API_KEY